D4476 4-(4-(2,3-二氢苯并[b][1,4]二恶英-6-基)-5-(吡啶-2-基)-1H-咪唑-2-基)苯甲酰胺
CAS 301836-43-1 MFCD09037526
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} Approved Therapeutics/Drug Candidates, Bioactive Small Molecule Alphabetical Index, Casein Kinase (CK), D-DIF, Diversification Ready Pharma-Developed Compounds, GlaxoSmithKline, Kinase/Phosphatase Biology, Serine/Threonine Kinase Biology, Serine/Threonine Kinase Inhibitors, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
- Approved Therapeutics/Drug Candidates, Bioactive Small Molecules, Casein Kinase (CK), Cell Biology, Cell Signaling and Neuroscience, D-DIF, GlaxoSmithKline, Kinase/Phosphatase Biology, Serine/Threonine Kinase Biology, Serine/Threonine Kinase Inhibitors
相关文献及参考
- Bain, J., et al., The selectivity of protein kinase inhibitors: a further update Biochem. J. 408 , 297-315, (2007) 摘要
- Rena, G., et al. , D4476, a cell-permeant inhibitor of CK1, suppresses the site-specific phosphorylation and nuclear exclusion of FOXO1a EMBO Rep. 5 , 60-65 , (2004) 摘要